Response to M. Brehmer: Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on ‘Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019’

Eemil Karttunen; Jan Oldenburg; Steinar  Thoresen; Anders  Ullén

doi:10.2340/sju.v58.10299

Response to M. Brehmer: Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on ‘Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019’

Authors

Eemil Karttunen Merck OY, an affiliate of Merck KGaA, Espoo, Finland https://orcid.org/0009-0007-2013-5171
Jan Oldenburg Department of Oncology, Akershus University Hospital, Oslo, Norway
Steinar Thoresen Merck AB NUF, an affiliate of Merck KGaA, Oslo, Norway
Anders Ullén Department of Oncology, Karolinska University Hospital, Solna, Sweden

DOI:

https://doi.org/10.2340/sju.v58.10299

Downloads

Download data is not yet available.

References

Brehmer M. Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on ‘Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019’. Scand J Urol. 2023;57(1–6):22–3. https://doi.org/10.1080/21681805.2022.2154384 DOI: https://doi.org/10.1080/21681805.2022.2154384

Karttunen E, Hervonen P, Hosseini A, Oldenburg J, Pappot H, Sairanen J, et al. Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019. Scand J Urol. 2023;57(1–6):15–21. https://doi.org/10.1080/21681805.2022.2138965 DOI: https://doi.org/10.1080/21681805.2022.2138965

Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN – a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49:725–36. https://doi.org/10.3109/02841861003782017 DOI: https://doi.org/10.3109/02841861003782017

Storm HH. Nordic cancer registration, a review of an invaluable source and example for surveillance, a research and public health for more than 70 years. Norsk Epidemiol. 2022;30:25–30. https://doi.org/10.5324/nje.v30i1-2.4973 DOI: https://doi.org/10.5324/nje.v30i1-2.4973

Laugesen K, Ludvigsson JF, Schmidt M, Gissler M, Valdimarsdottir UA, Lunde A, et al. Nordic Health Registry-based research: a review of health care systems and key registries. Clin Epidemiol. 2021;13:533–54. https://doi.org/10.2147/CLEP.S314959 DOI: https://doi.org/10.2147/CLEP.S314959

Russell B, Liedberg F, Hagberg O, Ullén A, Söderkvist K, Ströck V, et al. Risk of bladder cancer death in patients younger than a 50 with non-muscle-invasive and muscle-invasive bladder cancer. Scand J Urol. 2022;56:27–33. https://doi.org/10.1080/21681805.2021.2002399 DOI: https://doi.org/10.1080/21681805.2021.2002399

Downloads

Published

2023-06-01

How to Cite

Karttunen, E., Oldenburg, J., Thoresen, S. ., & Ullén, A. . (2023). Response to M. Brehmer: Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on ‘Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019’. Scandinavian Journal of Urology, 58, 20. https://doi.org/10.2340/sju.v58.10299

Download Citation

Issue

Vol. 58 (2023)

Section

Letter to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 58 (2023) all published articles, unless otherwise specified, are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.